SoftBank Group is currently experiencing a significant short-squeeze dynamic as its share price rallies, driven by renewed market enthusiasm for artificial intelligence. According to data from S3 Partners, the notional value of short positions in the Japanese technology investor reached $3.9 billion in September, the highest level recorded since 2015. As of September 11, short interest as a percentage of the float climbed to 2.27%, marking a one-year high.
The rally, which saw SoftBank shares gain over 25% in the first half of September, has been largely attributed to momentum surrounding OpenAI’s new GPT-6 Astra model. This price appreciation has placed immense pressure on bearish investors, who have incurred approximately $1 billion in paper losses during the month, bringing their year-to-date mark-to-market losses to roughly $1.2 billion.
This situation serves as a classic example of the risks inherent in betting against high-beta, AI-exposed assets. When short interest reaches multi-year highs, the potential for a rapid price reversal—or a "short squeeze"—increases, as bearish investors are forced to buy back shares to cover their positions, further fueling the upward momentum. For institutional observers, the SoftBank case highlights the volatility of the current AI-driven market cycle, where fundamental short theses can be quickly overwhelmed by speculative momentum.
Key Takeaways
- SoftBank Group shares rallied over 25% in September, driven by AI-related optimism surrounding OpenAI's GPT-6 Astra.
- Short sellers have faced approximately $1 billion in paper losses in September alone, with year-to-date losses reaching $1.2 billion.
- Short interest in SoftBank reached $3.9 billion, the highest level since 2015, creating significant short-squeeze risk.
Sources
- TradingView News — Report on SoftBank short interest and market losses, September 11, 2026.
Original reporting by TradingView. This article is desk analysis prepared by The Forensic Ledger from publicly available sources, summarized with citation to the original.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.
